Trials / Not Yet Recruiting
Not Yet RecruitingNCT07312773
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C
A Two-arm, Open-label, Single-sequence, Multiple-dose Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C in Healthy Adult Volunteers
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 55 (estimated)
- Sponsor
- Addpharma Inc. · Industry
- Sex
- All
- Age
- 19 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the pharmacokinetic interactions of AD-231A, AD-231B, and AD-231C in healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Treatment A(AD-231A) | AD-231A Oral Tablet |
| DRUG | Treatment B(AD-231B+AD-231C) | AD-231B+AD-231C Oral Tablet |
| DRUG | Treatment C(AD-231A+AD-231B+AD-231C) | AD-231A+AD-231B+AD-231C Oral Tablet |
Timeline
- Start date
- 2026-01-23
- Primary completion
- 2026-02-07
- Completion
- 2026-02-22
- First posted
- 2025-12-31
- Last updated
- 2025-12-31
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07312773. Inclusion in this directory is not an endorsement.